IFI44L
Interferon-induced protein 44-like
Also known as: C1orf29, GS3686, IF44L_HUMAN, TLDC5B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53G44
- Gene
- IFI44L
- Ensembl
- ENSG00000137959
- Chromosome
- 1
- Canonical length
- 452 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to be involved in immune response. Predicted to act upstream of or within cellular response to virus. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
452 residues, UniProt reviewed canonical sequence.
>Q53G44|IFI44L
1 MEVTTRLTWN DENHLRKLLG NVSLSLLYKS SVHGGSIEDM VERCSRQGCT ITMAYIDYNM
61 IVAFMLGNYI NLHESSTEPN DSLWFSLQKK NDTTEIETLL LNTAPKIIDE QLVCRLSKTD
121 IFIICRDNKI YLDKMITRNL KLRFYGHRQY LECEVFRVEG IKDNLDDIKR IIKAREHRNR
181 LLADIRDYRP YADLVSEIRI LLVGPVGSGK SSFFNSVKSI FHGHVTGQAV VGSDITSITE
241 RYRIYSVKDG KNGKSLPFML CDTMGLDGAE GAGLCMDDIP HILKGCMPDR YQFNSRKPIT
301 PEHSTFITSP SLKDRIHCVA YVLDINSIDN LYSKMLAKVK QVHKEVLNCG IAYVALLTKV
361 DDCSEVLQDN FLNMSRSMTS QSRVMNVHKM LGIPISNILM VGNYASDLEL DPMKDILILS
421 ALRQMLRAAD DFLEDLPLEE TGAIERALQP CILocalizationUniProt · AlphaFold · HPA
Whether an antibody against IFI44L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 76 nTPM
Expression across tissuesHPA
Tissue
- salivary gland: 76 nTPM
- spleen: 41 nTPM
- bone marrow: 40 nTPM
- gallbladder: 30 nTPM
- thymus: 30 nTPM
- ovary: 24 nTPM
Single-cell type
- microglia: 144 nCPM
- vascular endothelial cells: 117 nCPM
- thymocytes: 109 nCPM
- granulosa cells: 105 nCPM
- macrophages: 72 nCPM
- peritubular myoid cells: 64 nCPM
Immune cell
- intermediate monocyte: 11 nTPM
- NK-cell: 10 nTPM
- classical monocyte: 9.3 nTPM
- memory B-cell: 6.7 nTPM
- non-classical monocyte: 6.6 nTPM
- plasmacytoid DC: 5 nTPM
Brain region
- spinal cord: 65 nTPM
- medulla oblongata: 64 nTPM
- pons: 36 nTPM
- white matter: 26 nTPM
- midbrain: 25 nTPM
- hypothalamus: 22 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.52
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.21
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IFI44L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IFI44L as an antibody target. Whether an autoantibody or antibody against IFI44L could matter depends on whether native IFI44L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IFI44L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IFI44L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...